Tyra Biosciences (TYRA) Operating Leases (2021 - 2026)
Tyra Biosciences (TYRA) posted Operating Leases of $5.2 million for Q1 2026, down 2.42% on a QoQ basis from $5.3 million in Q4 2025, and down 8.55% year-over-year from $5.7 million in Q1 2025.
Tyra Biosciences (TYRA) Operating Leases (2021 - 2026) Analysis & Trends
Tyra Biosciences' Operating Leases history runs 6 years deep, the most recent figure standing at $5.2 million for Q1 2026.
- Quarterly Operating Leases fell 8.55% year-over-year to $5.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.2 million (down 8.55% YoY) and the FY2025 annual result came in at $5.3 million, down 8.12% from the prior year.
- Operating Leases was $5.2 million for Q1 2026 at Tyra Biosciences, down from $5.3 million in the prior quarter.
- Across five years, Operating Leases topped out at $6.2 million in Q4 2023 and bottomed at $2.4 million in Q1 2023.
- A 5-year average of $5.0 million and a median of $5.6 million in 2025 frame the typical range for Operating Leases.
- Annual changes were most pronounced in 2022 — Operating Leases soared 153.01% — and 2023, when it slumped 55.56%.
- Tyra Biosciences' Operating Leases stood at $2.5 million in 2022, then jumped by 150.44% to $6.2 million in 2023, then fell by 6.53% to $5.8 million in 2024, then decreased by 8.12% to $5.3 million in 2025, then decreased by 2.42% to $5.2 million in 2026.
- Business Quant data shows TYRA's Operating Leases at $5.2 million in Q1 2026, $5.3 million in Q4 2025, and $5.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Tyra Biosciences | 1.90 Bn | 1.90 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.21 Mn |
| Dec 31, 2025 | 5.34 Mn |
| Sep 30, 2025 | 5.46 Mn |
| Jun 30, 2025 | 5.58 Mn |
| Mar 31, 2025 | 5.70 Mn |
| Dec 31, 2024 | 5.81 Mn |
| Sep 30, 2024 | 5.92 Mn |
| Jun 30, 2024 | 6.02 Mn |
| Mar 31, 2024 | 6.12 Mn |
| Dec 31, 2023 | 6.22 Mn |
| Sep 30, 2023 | 5.96 Mn |
| Jun 30, 2023 | 5.93 Mn |
| Mar 31, 2023 | 2.44 Mn |
| Dec 31, 2022 | 2.48 Mn |
| Sep 30, 2022 | 2.51 Mn |
| Jun 30, 2022 | 2.55 Mn |
| Mar 31, 2022 | 5.50 Mn |
| Dec 31, 2021 | 981,000.00 |
| Sep 30, 2021 | 1.04 Mn |